Skip to main navigation Skip to search Skip to main content

A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa Inhibitor

Project: Research

Project Details

StatusFinished
Effective start/end date11/23/2209/12/24

Funding

  • Alexion Pharmaceuticals Incorporated: $38,290.00